Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junichiro Irie

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Journal of Diabetes Science and Technology|December 21, 2014
Insulin degludec requires lower bolus insulin doses than does insulin glargine in Japanese diabetic patients with insulin-dependent stateManaho Komuro, Gaku Inoue, Mitsuhisa Tabata, et al.
Journal of Clinical Medicine|January 6, 2018
Association of Maternal Factors with Perinatal Complications in Pregnancies Complicated with Diabetes: A Single-Center Retrospective AnalysisSho Endo, Yoshifumi Saisho, Kei Miyakoshi, et al.
Diabetologia|January 5, 2021
C-C motif chemokine receptor 9 regulates obesity-induced insulin resistance via inflammation of the small intestine in miceTakeru Amiya, Nobuhiro Nakamoto, Junichiro Irie, et al.
International Journal of Endocrinology|September 26, 2013
Past Obesity as well as Present Body Weight Status Is a Risk Factor for Diabetic NephropathyShu Meguro, Yusuke Kabeya, Karin Tanaka, et al.
Endocrine Journal|March 6, 2015
Efficacy and safety of liraglutide monotherapy compared with metformin in Japanese overweight/obese patients with type 2 diabetesKumiko Tanaka, Yoshifumi Saisho, Toshihide Kawai, et al.
Endocrine Journal|January 8, 2024
Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese menShintaro Yamaguchi, Junichiro Irie, Masanori Mitsuishi, et al.
International Journal of Endocrinology|September 3, 2013
Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)Takumi Hirata, Kengo Tomita, Toshihide Kawai, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2012
Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetesKeiichi Kodama, Momoko Horikoshi, Kyoko Toda, et al.
Annals of the New York Academy of Sciences|February 9, 2005
GAD-reactive T cells were mainly detected in autoimmune-related type 1 diabetic patients with HLA DR9Arata Itoh, Akira Shimada, Keiichi Kodama, et al.
Journal of Diabetes and Its Complications|July 8, 2017
GLP-1 receptor agonist, liraglutide, ameliorates hepatosteatosis induced by anti-CD3 antibody in female miceArata Itoh, Junichiro Irie, Hirotsune Tagawa, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Journal of Diabetes Science and Technology|December 21, 2014
Insulin degludec requires lower bolus insulin doses than does insulin glargine in Japanese diabetic patients with insulin-dependent stateManaho Komuro, Gaku Inoue, Mitsuhisa Tabata, et al.
Journal of Clinical Medicine|January 6, 2018
Association of Maternal Factors with Perinatal Complications in Pregnancies Complicated with Diabetes: A Single-Center Retrospective AnalysisSho Endo, Yoshifumi Saisho, Kei Miyakoshi, et al.
Diabetologia|January 5, 2021
C-C motif chemokine receptor 9 regulates obesity-induced insulin resistance via inflammation of the small intestine in miceTakeru Amiya, Nobuhiro Nakamoto, Junichiro Irie, et al.
International Journal of Endocrinology|September 26, 2013
Past Obesity as well as Present Body Weight Status Is a Risk Factor for Diabetic NephropathyShu Meguro, Yusuke Kabeya, Karin Tanaka, et al.
Endocrine Journal|March 6, 2015
Efficacy and safety of liraglutide monotherapy compared with metformin in Japanese overweight/obese patients with type 2 diabetesKumiko Tanaka, Yoshifumi Saisho, Toshihide Kawai, et al.
Endocrine Journal|January 8, 2024
Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese menShintaro Yamaguchi, Junichiro Irie, Masanori Mitsuishi, et al.
International Journal of Endocrinology|September 3, 2013
Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)Takumi Hirata, Kengo Tomita, Toshihide Kawai, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2012
Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetesKeiichi Kodama, Momoko Horikoshi, Kyoko Toda, et al.
Annals of the New York Academy of Sciences|February 9, 2005
GAD-reactive T cells were mainly detected in autoimmune-related type 1 diabetic patients with HLA DR9Arata Itoh, Akira Shimada, Keiichi Kodama, et al.
Journal of Diabetes and Its Complications|July 8, 2017
GLP-1 receptor agonist, liraglutide, ameliorates hepatosteatosis induced by anti-CD3 antibody in female miceArata Itoh, Junichiro Irie, Hirotsune Tagawa, et al.
Pageof 8